Next Article in Journal
N-[1-(2,5-Dimethyl-3-thienyl)ethylidene]-1,3-benzothiazol-2-amine
Previous Article in Journal
5-Methyl-4-oxo-4,6-dihydro-3H-pyridazino[4,5-b]carbazole-1-carbonitrile
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

(Benzoylamino)methyl 4-Hydroxybenzoate

1
Institute of Chemistry, Faculty of Natural Sciences & Mathematics, Ss. Cyril and Methodius University, Arhimedova 5, PO Box 162, 1000 Skopje, Macedonia
2
Department of Drug Design and Metabolism, Faculty of Pharmacy, Ss. Cyril and Methodious University, Vodnjanska 17, 1000 Skopje, Macedonia
*
Author to whom correspondence should be addressed.
Molbank 2010, 2010(1), M658; https://doi.org/10.3390/M658
Submission received: 14 January 2010 / Accepted: 22 February 2010 / Published: 25 February 2010

Abstract

:
(Benzoylamino)methyl 4-hydroxybenzoate (“Benzamidomethylparaben”) (3) was obtained from a reaction of 4-hydroxybenzoic acid (2) with a dioxane suspension of (benzamidomethyl)triethylammonium chloride (1). The phenolic group in 2 cannot be benzamidomethylated with 1 in aqueous media.

Parabens such as methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben and isobutylparaben are chemical compounds derived from 4-hydroxybenzoic acid (2) [1]. For almost one century they have been successfully used as antimicrobial preservatives in foods and beverages, pharmaceuticals and cosmetics [2]. In addition, parabens have been reported to have anticonvulsive, vasodilating, analgesic, and anesthetic effects in animals [3,4].
Considering toxicity, many results so far are inconclusive. Once entering the human body, parabens do not accumulate, but are rapidly absorbed, metabolized and excreted. Numerous acute toxicity studies as well as subchronic and chronic oral studies confirm their low toxicity, non-sensitivity and non-irritability [1,5,6]. Estrogen agonist properties of parabens have been documented with a wide variety of assay systems in vitro and in vivo [7,8]. However, research data related to the vulnerability of the paraben exposure in estrogen-sensitive period of implantation indicated that parabens may not be as potent as previously reported [6]. In addition, some of the parabens have also been shown to possess androgen antagonist activity, to act as inhibitors of sulfotransferase enzymes and to possess genotoxic activity, especially when multiple daily doses of parabens, combined with other ingredients, are applied [9,10,11,12,13,14,15].
So, in view of the long history of use of parabens and of these inconclusive data, there remains a need for detailed research and evaluation of their biological properties and it is continuously performed [16,17,18]. In parallel, the search for new ways of synthesis [19] or new parabens continues [20].
In this paper, we present the synthesis of a new paraben compound, i.e., “benzamidomethylparaben” [(benzoylamino)methyl 4-hydroxybenzoate]. The benzamidomethyl group can be found in many molecules with biological activity or it intermediates within the synthesis of different biologically active compounds [21,22,23,24,25] such as the 2-benzamidomethyl-3-oxybutanoates, which are used as intermediates in the preparation of (2R,3S)-2-benzamidomethyl-3-hydroxybutanoates [26,27,28] as chiral building blocks for the synthesis of biologically active carbapenems [29,30,31].
We have already reported [32] that phenols can be easily benzamidomethylated with (benzamidomethyl)triethylammonium chloride (1) in aqueous media (pH > 9), giving high yields of the corresponding ethers. Also, carboxylic acids give moderate yields of the corresponding esters in reactions with acetone or dioxane suspensions of 1 in the presence of a small amount of triethylamine (TEA) [33].
According to our research, 4-hydroxybenzoic acid (in which both a phenolic group and a carboxylic group are present) cannot be benzamidomethylated with 1 in aqueous media. The carboxylic group as a weak nucleophile in aqueous media does not react, but it deactivates the phenolic group in the molecule of 2. However, when the same reaction was performed in a dioxane suspension of 1 in the presence of TEA, a moderate to high yield of benzamidomethyl paraben (3) was obtained (Scheme 1).
For further evaluation, the biological properties of the newly synthesized compound, benzamidomethylparaben, will be investigated. Knowing that an ester chain is necessary for antimicrobial activity [1,2] and considering the fact that it is preserved in the molecule, one can expect that this compound could be used as preservative.
Scheme 1. Synthetic route to the title compound 3.
Scheme 1. Synthetic route to the title compound 3.
Molbank 2010 m658 sch001

Experimental

Compound 1 is not commercially available and it was synthesized as described previously [32].

(Benzoylamino)methyl 4-hydroxybenzoate (“Benzamidomethylparaben”) (3)

Finely powdered (benzamidomethyl)triethylammonium chloride (0.997 g, 3.68 mmol) was suspended in dioxane (30 mL). Triethylamine (0.2 mL) and 4-hydroxybenzoic acid (0.608 g, 4.40 mmol) were added to the suspension. The mixture was stirred at 50 °C for 4 h and left to cool at room temperature. After cooling, water was added to the mixture until occurrence of a precipitate. The typical yield of crude colorless crystals with m.p. of 148–154 °C was 75%. Purification was performed firstly by dissolving the product in dioxane (or acetone), followed by precipitation with water and then by recrystallization from CHCl3.
Melting point: 165–166 °C.
FT-IR (KBr): 3385 cm-1 (νNH); 3320 cm-1 (νOH); 1689 cm-1 (νOC=O); 1663 cm-1 Amide I; 1527 cm-1 Amide II
1H-NMR (300 MHz, DMSO-d6): δ/ppm 10.37 (s, 1H, OH); 9.63 (t, J = 6.5 Hz, 1H, NH); 7.96-6.85 (m, 9H, Ar); 5.56 (d, J = 6.7 Hz, 2H, N-CH2-O).
13C-NMR (75 MHz, DMSO-d6): δ/ppm 167.11 (C=O); 165.36 (C=O); 65.31 (CH2); Ar: 162.25, 133.25, 132.11, 131.64, 128.57, 127.66, 120.18, 115.50.
Anal. Calcd. (found) for C15H13NO4: C, 66.41 (66.29 ); H, 4.83 (4.86); N, 5.16 (5.31).

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

References and Notes

  1. Andersen, F.A. Final amended report on the safety assessment of methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben, and benzylparaben as used in cosmetic products. Int. J. Toxicol. 2008, 27 (Suppl. 4), 1–82. [Google Scholar]
  2. Lang, M.; Rye, R.M. Correlation between the antibacterial activity of some p-hydroxybenzoate esters and their cellular uptake. Microbios 1973, 7, 199–207. [Google Scholar] [PubMed]
  3. Bubnoff, M.V.; Schnell, D.; Vogt-Moykoff, J. Concerning the pharmacology of benzoic acid, p-chlorobenzoic acid, as well as p-hydroxybenzoic acid and its esters. Arzneim.-Forsch. 1957, 7, 340–344. [Google Scholar]
  4. Kitamura, Y. Effects of local anesthetics on the peripheral nerve and the spinal cord. Osaka City Med. J. 1979, 25, 7–24. [Google Scholar] [PubMed]
  5. Soni, M.G.; Carabin, I.G.; Burdock, G.A. Safety assessment of esters of p-hydroxybenzoic acid (paraben). Food Chem. Toxicol. 2005, 43, 985–1015. [Google Scholar] [CrossRef] [PubMed]
  6. Shaw, J.; de Catanzaro, D. Estrogenicity of parabens revisited: Impact of parabens on early pregnancy and an uterotrophic assay in mice. Reprod. Toxicol. 2009, 28, 26–31. [Google Scholar] [CrossRef] [PubMed]
  7. Darbre, P.D.; Aljarrah, A.; Miller, W.R.; Coldham, N.G.; Sauer, M.J.; Pope, G.S. Concentrations of parabens in human breast tumours. J. Appl. Toxicol. 2004, 24, 5–13. [Google Scholar] [CrossRef] [PubMed]
  8. Darbre, P.D.; Harvey, P.W. Paraben esters: Review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J. Appl. Toxicol. 2008, 28, 561–578. [Google Scholar] [CrossRef] [PubMed]
  9. Harvey, P.W.; Everett, D.J. Regulation of endocrine-disrupting chemicals: Critical overview and deficiencies in toxicology and risk assessment for human health. Best Pract. Res. Clin. Endoc. Met. 2006, 20, 145–165. [Google Scholar] [CrossRef] [PubMed]
  10. Golden, R.; Gandy, J.; Vollmer, G. A review of the endocrine activity of parabens and implications for potential risks to human health. Crit. Rev. Toxicol. 2005, 35, 435–445. [Google Scholar] [CrossRef] [PubMed]
  11. Soni, M.G.; Taylor, S.L.; Greenberg, N.A.; Burdock, G.A. Evaluation of the health aspects of methyl paraben: A review of the published literature. Food Chem. Toxicol. 2002, 40, 1335–1373. [Google Scholar] [CrossRef]
  12. Chen, J.; Ahn, K.C.; Gee, N.A.; Gee, S.J.; Hammock, B.D.; Lasley, B.L. Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products. Toxicol. Appl. Pharmacol. 2007, 221, 278–284. [Google Scholar] [CrossRef] [PubMed]
  13. Tavares, R.S.; Martins, F.C.; Oliveira, P.J.; Ramalho-Santos, J.; Peixoto, F.P. Parabens in male infertility—Is there a mitochondrial connection? Reprod. Toxicol. 2009, 27, 1–7. [Google Scholar] [CrossRef] [PubMed]
  14. Oishi, S. Effects of butylparaben on the male reproductive system in rats. Toxicol. Ind. Health 2001, 17, 31–39. [Google Scholar] [CrossRef] [PubMed]
  15. Oishi, S. Effects of propylparaben on the male reproductive system. Food Chem. Toxicol. 2002, 40, 1807–1813. [Google Scholar] [CrossRef]
  16. Maggi, L.; Carmona, M.; Zalacain, A.; Tomé, М.M.; Murcia, M.A.; Alonso, G.L. Parabens as agents for improving crocetin esters’ shelf-life in aqueous saffron extracts. Molecules 2009, 14, 1160–1170. [Google Scholar] [CrossRef] [PubMed]
  17. Asnani, V.M.; Verma, R.J. Ameliorative effects of ginger extract on paraben-induced lipid peroxidation in the liver of mice. Acta Pol. Pharm.-Drug Res. 2009, 66, 225–228. [Google Scholar]
  18. Vo, T.T.B.; Jeung, E. An evaluation of estrogenic activity of parabens using uterine calbindin-D9k gene in an immature rat model. Toxicol. Sci. 2009, 112, 68–77. [Google Scholar] [CrossRef] [PubMed]
  19. Hazarika, M.K.; Parajuli, R.; Phukan, P. Synthesis of parabens using montmorillonite K10 clay as Catalyst: A green protocol. Indian J. Chem. Technol. 2007, 14, 104–106. [Google Scholar]
  20. Quévrain, E.; Domart-Coulon, I.; Pernice, M.; Bourguet-Kondracki, M. Novel natural parabens produced by a Microbulbifer bacterium in its calcareous sponge host Leuconia nivea. Environ. Microbiol. 2009, 11, 1527–1539. [Google Scholar] [CrossRef] [PubMed]
  21. Tiwari, K.A.; Singh, K.V.; Bajpai, A.; Shukla, G.; Singh, S.; Mishra, K.A. Synthesis and biological properties of 4-(3H)-quinazolone derivatives. Eur. J. Med. Chem. 2007, 42, 1234–1238. [Google Scholar] [CrossRef] [PubMed]
  22. Zlotin, G.S.; Sharova, V.I.; Luk`yanov, A.O. Chemical properties of N-(amidomethyl)- and N-(imidomethyl)glycine derivatives 2. Reactions at alkoxycarbonyl and carboxyl groups. Rus. Chem. Bul. 1996, 45, 1680–1687. [Google Scholar] [CrossRef]
  23. Csomós, P.; Fodor, L.; Bernáth, G.; Csámpai, A.; Sohár, P. Synthesis of 4-thiaharmalan analogue 4-aryl-1,3-thiazino[5,6-b]indole derivatives by prevention of rearrangements to position two of the indole moiety. Tetrahedron 2008, 64, 8646–8651. [Google Scholar] [CrossRef]
  24. Csomós, P.; Fodor, L.; Bernáth, G.; Csámpai, A.; Sohár, P. An expeditious synthesis for g-carboline analogue 4-aryl-1,3-thiazino[6,5-b]indole derivatives via the trifluoromethanesulfonic acid-promoted isomerization of 3-amidomethylthioindole intermediates to 2-indolyl sulphides. Tetrahedron 2009, 65, 1475–1480. [Google Scholar] [CrossRef]
  25. Mai, A.; Artico, M.; Valente, S.; Cerbara, I.; Befani, O.; Turini, P.; Vedova, D.L.; Agostinelli, E. Synthesis and biochemical evaluation of (R)-5-acyloxymethyl- and (S)-5-acylaminomethyl-3-(1H-pyrrol-1-yl)-2-oxazolidinones as new anti-monoamine oxidase (anti-MAO) agents. ARKIVOC 2004, v, 32–43. [Google Scholar]
  26. Noyori, R.; Kitamura, M.; Ohkuma, T. Toward efficient asymmetric hydrogenation: Architectural and functional engineering of chiral molecular catalysts. PNAS 2004, 101, 5356–5362. [Google Scholar] [CrossRef] [PubMed]
  27. Cesarotti, E.; Rimoldi, I.; Spalluto, P.; Demartin, F. Chiral 1,4-bis-diphosphine ligands from optically active (Z)-olefines. Tetrahedron-Asymmetr. 2007, 18, 1278–1283. [Google Scholar] [CrossRef]
  28. Mateska, A.; Stojković, G.; Mikhova, B.; Mladenovska, K.; Popovski, E. Carbon-carbon bond formation in aqueous media. Benzamidomethylation of some carbon nucleophiles. ARKIVOC 2009, 131–140. [Google Scholar]
  29. Shimoda, K.; Kubota, N.; Hamada, H.; Kobayashi, T.; Hamada, H.; Shafi, S.M.; Nakajima, N. Production of (2R,3S)-2-benzamidomethyl-3-hydroxybutanoates by immobilized plant cells of parthenocissus tricuspidata. Biochemistry Insights 2009, 2, 5–7. [Google Scholar]
  30. Shimoda, K.; Kubota, N.; Hamada, H.; Hamada, H. Diastereoselective reduction of β-keto carbonyl compounds by cultured plant cells. Tetrahedron Lett. 2006, 47, 1541–1544. [Google Scholar] [CrossRef]
  31. Kumobayashi, H.; Miura, T.; Sayo, N.; Saito, T. The development of the new processes for manufacturing the key intermediates of β-lactam antibiotics. J. Syn. Org. Chem. Jpn. 1999, 57, 387–393. [Google Scholar] [CrossRef]
  32. Popovski, E.; Klisarova, L.; Vikic-Topic, D. Simple method for benzamidomethylation of phenols in water solution. Syn. Commun. 1999, 29, 3451–3458. [Google Scholar] [CrossRef]
  33. Popovski, E.; Klisarova, L.; Vikic-Topic, D. Benzamidomethylation with (benzamidomethyl)triethylammonium chloride 2. A simple method for benzamidomethylation of thiols, amines and carboxylic acids. Molecules 2000, 5, 927–936. [Google Scholar] [CrossRef]

Share and Cite

MDPI and ACS Style

Popovski, E.; Mladenovska, K. (Benzoylamino)methyl 4-Hydroxybenzoate. Molbank 2010, 2010, M658. https://doi.org/10.3390/M658

AMA Style

Popovski E, Mladenovska K. (Benzoylamino)methyl 4-Hydroxybenzoate. Molbank. 2010; 2010(1):M658. https://doi.org/10.3390/M658

Chicago/Turabian Style

Popovski, Emil, and Kristina Mladenovska. 2010. "(Benzoylamino)methyl 4-Hydroxybenzoate" Molbank 2010, no. 1: M658. https://doi.org/10.3390/M658

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop